智通财经APP讯，戴维医疗(300314.SZ)发布公告，公司全资子公司宁波维尔凯迪医疗器械有限公司于近日取得由浙江省药品监督管理局颁发的1项《受理通知书》，受理号为：械受20254012924，产品名称：一次性使用套管穿刺器。
一次性使用套管穿刺器由穿刺锥和穿刺套管组成，其使用灵活方便，穿刺插拔省力，阻气密封性能良好，同时保证内镜器械可通过穿刺器建立的工作通道进入腹部并进行操作。该产品可广泛应用于妇产科、普外科、肝胆外科、胃肠外科和泌尿外科等科室，具有较好的应用前景。
更多港股重磅资讯，下载智通财经app
更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.